{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:23:26Z","timestamp":1793391806975,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2015JC3029"],"award-info":[{"award-number":["2015JC3029"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.eplepsyres.2017.02.015","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T02:49:25Z","timestamp":1488250165000},"page":"64-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy"],"prefix":"10.1016","volume":"132","author":[{"given":"Can","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbalip.2007.01.010","article-title":"Studies on the extra-mitochondrial CoA-ester formation of valproic and D4-valproic acids","volume":"1771","author":"Aires","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0010","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3109\/15376516.2010.497977","article-title":"Influence of CYP2C9 polymorphism on metabolism of valproate and its hepatotoxin metabolite in Iranian patients","volume":"20","author":"Amini-shirazi","year":"2010","journal-title":"Toxicol. Mech. Method"},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0003-9861(83)90602-1","article-title":"Influence of valproic acid on hepatic carbohydrate and lipid metabolism","volume":"223","author":"Becker","year":"1983","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0020","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10528-009-9273-z","article-title":"Comparative analyses of disease risk genes belonging to the acyl-coa synthetase medium-chain (acsm) family in human liver and cell lines","volume":"47","author":"Boomgaarden","year":"2009","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0025","article-title":"Correlation research of VPA gene polymorphisms related metabolism and its adverse reactions","author":"Chen","year":"2012","journal-title":"The Thirteenth National Symposium on Clinical Pharmacology"},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.tpj.6500210","article-title":"Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomes","volume":"3","author":"Ho","year":"2003","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfl096","article-title":"Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1\/*1 genotype","volume":"94","author":"Kiang","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/mnfr.200500241","article-title":"The L513S polymorphism in medium-chain acyl-CoA synthetase 2 (MACS2) is associated with risk factors of the metabolic syndrome in a Caucasian study population","volume":"50","author":"Lindner","year":"2006","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00008571-200011000-00003","article-title":"Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C","volume":"10","author":"Noritaka","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(99)00359-2","article-title":"Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population","volume":"448","author":"Oscarson","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0055","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0022-3565(24)37076-4","article-title":"Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene valproic acid","volume":"283","author":"Sadeque","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0060","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1528-1157.1993.tb02419.x","article-title":"Valproate (VPA) metabolites in various clinical conditions of probable vpa-associated hepatotoxicity","volume":"34","author":"Siemes","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.taap.2012.08.018","article-title":"Assessment of the role of in situ generated (E)-2, 4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes","volume":"264","author":"Surendradoss","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2165\/00003088-200140080-00003","article-title":"Pharmacogenetics of warfarin elimination and its clinical implications","volume":"40","author":"Takahashi","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0080","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.clineuro.2010.01.002","article-title":"The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients","volume":"112","author":"Tan","year":"2010","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1528-1157.1988.tb03758.x","article-title":"Valproate metabolites and hepatotoxicity in an epileptic population","volume":"29","author":"Tennison","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.02.015_bib0090","first-page":"1221","article-title":"Simultaneous determination of valproic acid and its hepatotoxic metabolite by gas chromatography-mass spectrometry","volume":"50","author":"Wang","year":"2015","journal-title":"Chin. Pharm. J."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117301122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117301122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:36:14Z","timestamp":1760276174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121117301122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":18,"alternative-id":["S0920121117301122"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.02.015","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}